Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections
- PMID: 21732819
 - PMCID: PMC3166201
 - DOI: 10.1089/omi.2011.0032
 
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections
Abstract
In this article we define vaccinomics as the integration of immunogenetics and immunogenomics with systems biology and immune profiling. Vaccinomics is based on the use of cutting edge, high-dimensional (so called "omics") assays and novel bioinformatics approaches to the development of next-generation vaccines and the expansion of our capabilities in individualized medicine. Vaccinomics will allow us to move beyond the empiric "isolate, inactivate, and inject" approach characterizing past vaccine development efforts, and toward a more detailed molecular and systemic understanding of the carefully choreographed series of biological processes involved in developing viral vaccine-induced "immunity." This enhanced understanding will then be applied to overcome the obstacles to the creation of effective vaccines to protect against pathogens, particularly hypervariable viruses, with the greatest current impact on public health. Here we provide an overview of how vaccinomics will inform vaccine science, the development of new vaccines and/or clinically relevant biomarkers or surrogates of protection, vaccine response heterogeneity, and our understanding of immunosenescence.
Figures
              
              
              
              
                
                
                References
- 
    
- Allman D. Miller J.P. B cell development and receptor diversity during aging. Curr Opin Immunol. 2005a;17:463–467. - PubMed
 
 - 
    
- Allman D. Miller J.P. The aging of early B-cell precursors. Immunol Rev. 2005b;205:18–29. - PubMed
 
 - 
    
- Anders J.F. Jacobson R.M. Poland G.A. Jacobsen S.J. Wollan P.C. Secondary failure rates of measles vaccines: a metaanalysis of published studies. Pediatr Infect Dis J. 1996;15:62–66. - PubMed
 
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
